ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New York » Critical Care Medicine

Top Critical Care Medicine Prescribers in New York

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ARUN ARORA MD

Critical Care Medicine

13,197

$648K

347
292 are 65+

12%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 51%

$49
Average prescription price

Avg: $247

RAKESH SHARMA M.D.

Critical Care Medicine

6,001

$329K

228
188 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

10%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 51%

$55
Average prescription price

Avg: $247

ALI EL ATAT M.D.

Critical Care Medicine

2,995

$456K

269
183 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

69%
prescriptions for brand name drugs

Avg: 51%

$152
Average prescription price

Avg: $247

MOHAMED RAHMAN MD

Critical Care Medicine

2,942

$198K

135
113 are 65+

18%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 51%

$67
Average prescription price

Avg: $247

ROXANA SULICA M.D.,

Critical Care Medicine

2,564

$6.32M

163
99 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

71%
prescriptions for brand name drugs

Avg: 51%

$2467
Average prescription price

Avg: $247

MIKHAEL RISMAN M.D.

Critical Care Medicine

1,953

$91.5K

131
73 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 51%

$47
Average prescription price

Avg: $247

MOHAMMAD ZAMAN MD

Critical Care Medicine

1,709

$564K

230
174 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

70%
prescriptions for brand name drugs

Avg: 51%

$330
Average prescription price

Avg: $247

MAURICE BEER M.D.

Critical Care Medicine

1,709

$145K

141
121 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 51%

$85
Average prescription price

Avg: $247

IRA WAGNER M.D.

Critical Care Medicine

1,709

$122K

89
76 are 65+

12%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 51%

$72
Average prescription price

Avg: $247

DANY ELSAYEGH M.D

Critical Care Medicine

1,633

$209K

265
216 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

58%
prescriptions for brand name drugs

Avg: 51%

$128
Average prescription price

Avg: $247

WOJCIECH SKRZYPIEC MD

Critical Care Medicine

1,627

$105K

66
56 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 51%

$64
Average prescription price

Avg: $247

JACK PARILLO MD

Critical Care Medicine

1,621

$117K

175
133 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

9%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 51%

$72
Average prescription price

Avg: $247

JOSEPH SARACENO DO

Critical Care Medicine

1,478

$292K

200
177 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

66%
prescriptions for brand name drugs

Avg: 51%

$198
Average prescription price

Avg: $247

RONALD ZIELINSKI MD

Critical Care Medicine

1,347

$523K

203
172 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

83%
prescriptions for brand name drugs

Avg: 51%

$388
Average prescription price

Avg: $247

TERENCE BRADY M.D.

Critical Care Medicine

1,170

$68.3K

114
101 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 51%

$58
Average prescription price

Avg: $247

NEERAJ KATRIYAR MD

Critical Care Medicine

1,138

$86.8K

69
55 are 65+

30%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 51%

$76
Average prescription price

Avg: $247

THOMAS NEWMAN M.D.

Critical Care Medicine

1,055

$108K

124
93 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

66%
prescriptions for brand name drugs

Avg: 51%

$103
Average prescription price

Avg: $247

MARK SLOANE M.D.

Critical Care Medicine

1,018

$196K

134
114 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

67%
prescriptions for brand name drugs

Avg: 51%

$192
Average prescription price

Avg: $247

LAURENCE ENGELBERG MD

Critical Care Medicine

963

$247K

156
111 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

79%
prescriptions for brand name drugs

Avg: 51%

$256
Average prescription price

Avg: $247

BARBARA JEAN WILK M.D.

Critical Care Medicine

898

$80.8K

46
36 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 51%

$90
Average prescription price

Avg: $247

PRABHAT SONI MD

Critical Care Medicine

880

$58.9K

52
43 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

43%
prescriptions for brand name drugs

Avg: 51%

$67
Average prescription price

Avg: $247

JEFFREY ZWANG MD

Critical Care Medicine

848

$203K

142
114 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

75%
prescriptions for brand name drugs

Avg: 51%

$239
Average prescription price

Avg: $247

IRINA SHPAK MD

Critical Care Medicine

831

$112K

100
79 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

81%
prescriptions for brand name drugs

Avg: 51%

$135
Average prescription price

Avg: $247

DAVID POCH M.D.

Critical Care Medicine

774

$1.76M

48
22 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

58%
prescriptions for brand name drugs

Avg: 51%

$2276
Average prescription price

Avg: $247

SAMIR FAHMY M.D.

Critical Care Medicine

751

$105K

107
74 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

78%
prescriptions for brand name drugs

Avg: 51%

$140
Average prescription price

Avg: $247

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank